Telomeric repeat-binding factor 2
(Redirected from TERF2)
Telomeric Repeat-binding Factor 2[edit | edit source]
Telomeric repeat-binding factor 2 (TERF2) is a crucial protein involved in the maintenance and protection of telomeres, the specialized structures at the ends of chromosomes. TERF2 is part of the shelterin complex, a group of proteins that specifically bind to telomeric DNA and regulate its structure and function.
Structure[edit | edit source]
TERF2 is characterized by several distinct domains that contribute to its function. The protein contains a Myb domain, which is responsible for binding to the telomeric DNA sequence. Additionally, TERF2 has a TRFH (TERF2 homology) domain that mediates protein-protein interactions, allowing it to recruit other components of the shelterin complex.
Function[edit | edit source]
The primary role of TERF2 is to protect telomeres from being recognized as sites of DNA damage. It achieves this by facilitating the formation of a T-loop structure, where the single-stranded 3' overhang of the telomere invades the double-stranded region, effectively hiding the chromosome end. This structure prevents the activation of DNA damage response pathways that would otherwise lead to inappropriate repair activities.
TERF2 also plays a role in the recruitment of other proteins to the telomere. It interacts with various client proteins that are involved in telomere maintenance and DNA repair processes.
Role in Telomere Maintenance[edit | edit source]
TERF2 is essential for the stability and integrity of telomeres. By maintaining the T-loop structure, TERF2 prevents the activation of ATM and ATR kinase pathways, which are typically triggered by DNA double-strand breaks. This protective function is crucial for preventing chromosomal instability and genomic instability, which can lead to cancer and other age-related diseases.
Clinical Significance[edit | edit source]
Dysfunction of TERF2, whether through mutation or altered expression, can lead to telomere shortening and genomic instability. This has been implicated in various diseases, including cancer and premature aging syndromes. Understanding the precise mechanisms by which TERF2 operates is therefore of great interest in the field of oncology and gerontology.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD